about
Incorporation of a Stress Reducing Mobile App in the Care of Patients With Type 2 Diabetes: A Prospective Study.Digital therapy in diabetes.Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease.Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome study.Declare-Timi 58: Participants' Baseline Characteristics.Validity of Diagnostic Codes and Estimation of Prevalence of Diabetic Foot Ulcers using a Large Electronic Medical Record DatabaseDigital Diabetes Care System Observations from a Pilot Evaluation Study in VietnamCardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trialSafety of dapagliflozin in a broad population of patients with type 2 diabetes - analyses from the DECLARE - TIMI 58 studyAcute renal outcomes with sodium-glucose co-transporter-2 inhibitors: Real-world data analysisEfficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 StudyPrediction of progression from pre-diabetes to diabetes: Development and validation of a machine learning modelAssociation of Inpatient Glucose Measurements With Amputations in Patients Hospitalized With Acute Diabetic FootHypoglycemia and its management in primary care settingImpact of Flash Glucose Monitoring on Glucose Control and Hospitalizations in Type 1 Diabetes: A Nationwide Cohort Study
P50
Q33790503-43A46928-1779-41B2-B896-5779B23E8854Q40502478-2FC4527F-4072-4B09-9D1C-505BC2D140C0Q47676770-69700BFA-50A0-4982-94BF-907B99435B18Q48257790-28ABC702-A0D0-4E55-B41F-0D58B686E09CQ48264148-3BF2B29A-AB93-4011-B2B0-6446E87AF4AFQ58590979-02ED87C4-DD74-4E82-81BD-D35659C552E3Q89578597-57510BDF-8B79-452A-82CE-31D51EBFB2B4Q89851177-0DC9BD3A-1390-4F59-87F9-AA3DD889F8E0Q90841104-FD0D7BC3-703B-44F4-866A-02CAEE4385C3Q91397700-AA83396B-5EAC-4674-A189-AFFD233252A8Q92023727-AA7E3CD0-A105-4E64-B0DF-B72B88A36B67Q92679305-E5FA98D1-1690-4F15-B66E-BA23076C200EQ93071398-AC29A3DB-C027-4F08-B84E-4BD9A4DC3ACAQ93339143-02D82B38-8A03-48BD-85D3-8C97DD914E70Q95940698-EBD51382-6C54-4ABE-95AE-304E3EF2D8A8
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7830-9994
@en
name
Avivit Cahn
@ast
Avivit Cahn
@en
Avivit Cahn
@es
Avivit Cahn
@nl
type
label
Avivit Cahn
@ast
Avivit Cahn
@en
Avivit Cahn
@es
Avivit Cahn
@nl
prefLabel
Avivit Cahn
@ast
Avivit Cahn
@en
Avivit Cahn
@es
Avivit Cahn
@nl
P106
P31
P496
0000-0002-7830-9994